HomeVSTM • NASDAQ
add
Verastem Inc
Previous close
$6.38
Day range
$6.13 - $6.79
Year range
$4.01 - $11.25
Market cap
553.36M USD
Avg Volume
1.59M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 17.54M | — |
Operating expense | 56.40M | 78.53% |
Net income | -32.92M | 49.01% |
Net profit margin | -187.72 | — |
Earnings per share | -0.46 | 23.47% |
EBITDA | -41.18M | -30.38% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 204.99M | 130.80% |
Total assets | 246.44M | 142.71% |
Total liabilities | 189.24M | 45.09% |
Total equity | 57.20M | — |
Shares outstanding | 87.84M | — |
Price to book | 8.62 | — |
Return on assets | -48.99% | — |
Return on capital | -94.99% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -32.92M | 49.01% |
Cash from operations | -29.95M | -19.34% |
Cash from investing | -1.34M | — |
Cash from financing | 98.58M | 13,186.12% |
Net change in cash | 67.28M | 376.24% |
Free cash flow | -15.46M | -14.52% |
About
Verastem, Inc., doing business as Verastem Oncology, is an American pharmaceutical company that develops medicines to treat certain cancers. Headquartered and founded in Boston, Massachusetts, the firm is a member of NASDAQ Biotechnology Index. Wikipedia
Founded
2010
Headquarters
Website
Employees
102
